Last reviewed · How we verify

Intraoperative anesthetic strategy by Propofol

Assistance Publique - Hôpitaux de Paris · Phase 2 active Small molecule

Intraoperative anesthetic strategy by Propofol is a GABA_A receptor agonist Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development for General anesthesia, Sedation.

Propofol acts as a GABA_A receptor agonist.

Propofol acts as a GABA_A receptor agonist. Used for General anesthesia, Sedation.

At a glance

Generic nameIntraoperative anesthetic strategy by Propofol
SponsorAssistance Publique - Hôpitaux de Paris
Drug classGABA_A receptor agonist
TargetGABA_A receptor
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 2

Mechanism of action

Propofol binds to the GABA_A receptor, enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA), leading to sedative, hypnotic, and amnestic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intraoperative anesthetic strategy by Propofol

What is Intraoperative anesthetic strategy by Propofol?

Intraoperative anesthetic strategy by Propofol is a GABA_A receptor agonist drug developed by Assistance Publique - Hôpitaux de Paris, indicated for General anesthesia, Sedation.

How does Intraoperative anesthetic strategy by Propofol work?

Propofol acts as a GABA_A receptor agonist.

What is Intraoperative anesthetic strategy by Propofol used for?

Intraoperative anesthetic strategy by Propofol is indicated for General anesthesia, Sedation.

Who makes Intraoperative anesthetic strategy by Propofol?

Intraoperative anesthetic strategy by Propofol is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

What drug class is Intraoperative anesthetic strategy by Propofol in?

Intraoperative anesthetic strategy by Propofol belongs to the GABA_A receptor agonist class. See all GABA_A receptor agonist drugs at /class/gaba-a-receptor-agonist.

What development phase is Intraoperative anesthetic strategy by Propofol in?

Intraoperative anesthetic strategy by Propofol is in Phase 2.

What are the side effects of Intraoperative anesthetic strategy by Propofol?

Common side effects of Intraoperative anesthetic strategy by Propofol include Respiratory depression, Hypotension, Bradycardia.

What does Intraoperative anesthetic strategy by Propofol target?

Intraoperative anesthetic strategy by Propofol targets GABA_A receptor and is a GABA_A receptor agonist.

Related